Instituto Cardiovascular de Buenos Aires

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Amyloidosis1 trial
• Heart failure1 trial
• High blood pressure1 trial
• Pulmonary arterial hypertension1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• GB002, Inc.1 trial
• Instituto Cardiovascular de Buenos Aires1 trial
• Ionis Pharmaceuticals, Inc.1 trial

Running trials

• Active, not recruiting

  ReDS-Guided Decongestion in Acute Heart Failure (ReDS-LATAM HF)

  NCT07600398· Instituto Cardiovascular de Buenos Aires· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Ionis Pharmaceuticals, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis1 recruiting

Closed trials

• Completed

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· Phase 3· GB002, Inc.· Source